heparin sodium in 0.9% sodium chloride injection Dosage and Administration

()

2 DOSAGE AND ADMINISTRATION

2.1 Preparation for Administration

Do not administer unless solution is clear and seal is intact.Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Warning: Do not use plastic containers in series connection. Such use could result in air embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is completed.

Do not use Heparin Sodium in Sodium Chloride Injection as a “catheter lock flush” product.

Do not admix with other drugs. Discard unused portion.

To Open

Tear outer wrap and remove solution container.

Preparation for Administration

(Use aseptic technique)

1.
Close flow control clamp of administration set.
2.
Remove cover from outlet port at bottom of container.
3.
Insert piercing pin of administration set into port with a twisting motion until the set is firmly seated.
NOTE: When using a vented administration set, replace bacterial retentive air filter with piercing pin cover. Insert piercing pin with twisting motion until shoulder of air filter housing rests against the outlet port flange.
4.
Suspend container from hanger.
5.
Squeeze and release drip chamber to establish proper fluid level in chamber.
6.
Attach venipuncture device to set.
7.
Open clamp to expel air from set and venipuncture device. Close clamp.
8.
Perform venipuncture.
9.
Regulate rate of administration with flow control clamp.

2.2 Recommended Dosage for Maintenance of Catheter Patency

The recommended starting dose is 6 units per hour by intravenous infusion through an intravenous catheter to maintain catheter patency.

Find heparin sodium in 0.9% sodium chloride injection medical information:

Find heparin sodium in 0.9% sodium chloride injection medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

heparin sodium in 0.9% sodium chloride injection Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

Dosage and Administration

2 DOSAGE AND ADMINISTRATION

2.1 Preparation for Administration

Do not administer unless solution is clear and seal is intact.Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Warning: Do not use plastic containers in series connection. Such use could result in air embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is completed.

Do not use Heparin Sodium in Sodium Chloride Injection as a “catheter lock flush” product.

Do not admix with other drugs. Discard unused portion.

To Open

Tear outer wrap and remove solution container.

Preparation for Administration

(Use aseptic technique)

1.
Close flow control clamp of administration set.
2.
Remove cover from outlet port at bottom of container.
3.
Insert piercing pin of administration set into port with a twisting motion until the set is firmly seated.
NOTE: When using a vented administration set, replace bacterial retentive air filter with piercing pin cover. Insert piercing pin with twisting motion until shoulder of air filter housing rests against the outlet port flange.
4.
Suspend container from hanger.
5.
Squeeze and release drip chamber to establish proper fluid level in chamber.
6.
Attach venipuncture device to set.
7.
Open clamp to expel air from set and venipuncture device. Close clamp.
8.
Perform venipuncture.
9.
Regulate rate of administration with flow control clamp.

2.2 Recommended Dosage for Maintenance of Catheter Patency

The recommended starting dose is 6 units per hour by intravenous infusion through an intravenous catheter to maintain catheter patency.

Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information. 8AM-9PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.